Concepedia

Mendi A. Higgins

MA

Statistics

Publications

8

Citations

177

H-Index

8

Active since

2005

Affiliations

Bristol-Myers Squibb (United States)(Current)

Mendi A. Higgins is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, neuropharmacology, and medicinal chemistry.

Publications per year

2005–2019

8

Publications

8

Synthesis and SAR of indole-and 7-azaindole-1,3-dicarboxamide hydroxyethylamine inhibitors of BACE-1

Lawrence R. Marcin, Mendi A. Higgins, F. Christopher Zusi et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 37 citations

, , +9

Conformationally Restricted Homotryptamines. 2. Indole Cyclopropylmethylamines as Selective Serotonin Reuptake Inhibitors

Ronald J. Mattson, John D. Catt, Derek J. Denhart et al. · Journal of Medicinal Chemistry · 2005 · 34 citations · Full text

, , +17

Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists

Kevin W. Gillman, Mendi A. Higgins, Graham S. Poindexter et al. · Bioorganic & Medicinal Chemistry · 2006 · 23 citations

, , +7

Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481

Kenneth M. Boy, Jason Guernon, Dmitry Zuev et al. · ACS Medicinal Chemistry Letters · 2019 · 22 citations · Full text

, , +9

Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor

Dalton King, Derek J. Denhart, Jeffrey A. Deskus et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 22 citations · Full text

, , +14

1–5 of 8